French market access strategy
Help your teams navigate market access pathways, local regulatory realities, and sustainable commercial planning in France.
Services
Patient journey intelligence and market access support for pharma and biotech teams.
Elliogen brings together patient pathway insight, launch strategy, and specialist commercial intelligence to help life sciences companies enter and grow in France with clarity.
What we offer
Strategic support across patient insight, access, and launch execution.
Exploitant support in France
Build the right local operating model with practical exploitant support for launch readiness and ongoing commercial execution.
Patient journey mapping in France
Map the patient pathway, access barriers, care flow, and stakeholder context that influence adoption and launch performance.
Pharma launch planning
Turn launch complexity into a clear roadmap with milestones, local stakeholder strategy, and operational support.
PatientGroups by Phormulate Ltd
PAG mapping and patient pathway intelligence to reveal where patients, decision-makers, and treatment pathways intersect.
IndicationIQ by IndicationIQ Ltd
Pharma social listening and indication intelligence for monitoring signals, sentiment, and emerging treatment narratives.
How we work
- We map the patient journey, care pathways, and stakeholder context that shape access and launch decisions.
- We connect local market access strategy with practical execution and commercial planning.
- We bring in specialist capabilities such as PAG mapping and social listening when a project needs deeper signal intelligence.